» Articles » PMID: 10359808

Matrix Metalloproteinase Deficiencies Affect Contact Hypersensitivity: Stromelysin-1 Deficiency Prevents the Response and Gelatinase B Deficiency Prolongs the Response

Overview
Specialty Science
Date 1999 Jun 9
PMID 10359808
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Matrix metalloproteinases (MMPs) are expressed by T cells and macrophages, but there is a paucity of evidence for their role in immune responses. We have studied mice with deficiencies of stromelysin-1 (MMP-3) or gelatinase B (MMP-9) in a dinitrofluorobenzene (DNFB)-induced model of contact hypersensitivity (CHS). Stromelysin-1-deficient mice showed a markedly impaired CHS response to topical DNFB, although they responded normally to cutaneously applied phenol, an acute irritant. Lymphocytes from lymph nodes of DNFB-sensitized stromelysin-1-deficient mice did not proliferate in response to specific soluble antigen dinitrobenzenesulfonic acid, but did proliferate identically to lymph node lymphocytes from wild-type mice when presented with the mitogen Con A. An intradermal injection of stromelysin-1 immediately before DNFB sensitization rescued the impaired CHS response to DNFB in stromelysin-1-deficient mice. Unlike stromelysin-1-deficient mice, gelatinase B-deficient mice exhibited a CHS response comparable to wild-type controls at 1 day postchallenge, but the response persisted beyond 7 days in contrast to the complete resolution observed in wild-type mice by 7 days. However, gelatinase B-deficient mice had a normal rate of resolution of acute inflammation elicited by cutaneous phenol. Gelatinase B-deficient mice failed to show IL-10 production at the site of CHS, an essential feature of resolution in control mice. These results indicate that stromelysin-1 and gelatinase B serve important functions in CHS. Stromelysin-1 is required for initiation of the response, whereas gelatinase B plays a critical role in its resolution.

Citing Articles

Cord blood-derived biologics lead to robust axonal regeneration in benzalkonium chloride-injured mouse corneas by modulating the Il-17 pathway and neuropeptide Y.

Huang R, Su C, Zhang N, Shi C, Pu G, Ding Y Mol Med. 2024; 30(1):2.

PMID: 38172658 PMC: 10763178. DOI: 10.1186/s10020-023-00772-w.


Determination of Chemical Irritation Potential Using a Defined Gene Signature Set on Tissue-Engineered Human Skin Equivalents.

Harding A, Murdoch C, Danby S, Hasan M, Nakanishi H, Furuno T JID Innov. 2021; 1(2):100011.

PMID: 34909715 PMC: 8659397. DOI: 10.1016/j.xjidi.2021.100011.


Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients.

Michalak-Stoma A, Bartosinska J, Raczkiewicz D, Kowal M, Krasowska D, Chodorowska G Mediators Inflamm. 2021; 2021:9913798.

PMID: 34305455 PMC: 8263227. DOI: 10.1155/2021/9913798.


SARS-CoV-2 and pathological matrix remodeling mediators.

Guizani I, Fourti N, Zidi W, Feki M, Allal-Elasmi M Inflamm Res. 2021; 70(8):847-858.

PMID: 34286362 PMC: 8294315. DOI: 10.1007/s00011-021-01487-6.


Intricate Relationship Between Adaptive and Innate Immune System in Allergic Contact Dermatitis.

Azeem M, Kader H, Kerstan A, Hetta H, Serfling E, Goebeler M Yale J Biol Med. 2020; 93(5):699-709.

PMID: 33380932 PMC: 7757059.


References
1.
Ferguson T, Dube P, Griffith T . Regulation of contact hypersensitivity by interleukin 10. J Exp Med. 1994; 179(5):1597-604. PMC: 2191501. DOI: 10.1084/jem.179.5.1597. View

2.
Phanuphak P, Moorhead J, Claman H . Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation. J Immunol. 1974; 112(1):115-23. View

3.
Blauvelt A, Katz S, Udey M . Human Langerhans cells express E-cadherin. J Invest Dermatol. 1995; 104(2):293-6. DOI: 10.1111/1523-1747.ep12612830. View

4.
Goetzl E, Banda M, Leppert D . Matrix metalloproteinases in immunity. J Immunol. 1996; 156(1):1-4. View

5.
Kondo S, Beissert S, Wang B, Fujisawa H, Kooshesh F, Stratigos A . Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. J Invest Dermatol. 1996; 106(5):993-1000. DOI: 10.1111/1523-1747.ep12338505. View